Clinical trial
rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets
NCT00222625 · University Of Perugia, Other · Unknown status
Key facts
| NCT number | NCT00222625 |
|---|---|
| Title | rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets |
| Official title | Randomized, Open, Prospective, Multicenter Pilot Study to Evaluate the Efficacy and Safety of Activated Recombinant Factor VII in Acute Intracerebral Haemorrhage in Patients Treated With Oral Anticoagulants or Antiplatelets Agents. |
| Lead sponsor | University Of Perugia, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Intracerebral Hemorrhage |
| Intervention type | Drug |
| Interventions | rFVIIa + (vit K in AO patients), FFP or aPCC+ vit K in AO treated patients |
| Enrollment | 32 |
| Start date | Sep 1, 2005 |
| Completion | Sep 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Sep 20, 2006 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: